Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients

Clinical trial NCT00041782 · TERMINATED

Trial details

NCT number: NCT00041782
Sponsor: M.D. Anderson Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Neoplasms Deep Vein Thrombosis

Start date: 2000-10-01
Primary completion: 2005-01-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.